Fate Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FATE research report →
About the company
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating advanced, programmed cellular immunotherapies. These innovative treatments are designed to combat cancer and various immune disorders across the globe.
- CEO
- Bahram Valamehr
- IPO
- 2013
- Employees
- 181
- HQ
- San Diego, CA, US
Price Chart
- Market Cap
- $340.35M
- P/E
- -2.68
- P/S
- 53.89
- P/B
- 1.95
- EV/EBITDA
- -3.22
- Div Yield
- 0.00%
- Gross Margin
- -415.79%
- Op Margin
- -2207.47%
- Net Margin
- -2056.79%
- ROE
- -58.89%
- ROIC
- -53.84%
- Revenue
- $6.65M · -51.24%
- Net Income
- $-136,315,000 · 26.82%
- EPS
- $-1.15 · 29.88%
- Op Income
- $-147,704,000
- FCF YoY
- 9.36%
- 52W High
- $3.21
- 52W Low
- $0.91
- 50D MA
- $2.05
- 200D MA
- $1.41
- Beta
- 2.52
- Avg Volume
- 3.81M
Get TickerSpark's AI analysis on FATE
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 12, 26 | Redmile Group, LLC | other | 87,900 |
| Jun 12, 26 | Lee Michael Stewart | other | 87,900 |
| Jun 12, 26 | Xu Yuan | other | 87,900 |
| Jun 12, 26 | Jooss Karin | other | 87,900 |
| Jun 12, 26 | EPSTEIN ROBERT S | other | 87,900 |
| Jun 12, 26 | Agarwal Shefali | other | 87,900 |
| Jun 12, 26 | ABERNETHY MATT | other | 87,900 |
| Jun 12, 26 | RASTETTER WILLIAM H | other | 87,900 |
| Jun 12, 26 | Hamill Laura | other | 175,800 |
| Jun 12, 26 | Hamill Laura | other | 0 |
Our FATE coverage
Recent articles, reports, and earnings notes.
No research on FATE yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FATE report →Similar companies
Peers in the same neighborhood.